102 1.2.2. Les anomalies histologiques retrouvées, p.104 ,
108 2.1.3. Le test respiratoire à l'urée marquée, p.110 ,
118 3.1. La prévalence de Helicobacter pylori dans les pathologies digestives 118 3.1.1. La prévalence de Helicobacter pylori en cas de reflux gastro-oesophagien ... 118 3.1.2. La prévalence de Helicobacter pylori en cas de maladie ulcéreuse, p.120 ,
125 3.3.1. Le choix de la méthode diagnostique non invasive 125 3.3.1.1. Le test respiratoire (c.f. chapitre 2.1.3.), p.126 ,
127 3.4.1.1. Effet de l'éradication en cas de dyspepsie non explorée Effet de l'éradication de Helicobacter pylori sur le risque de cancer gastrique, p.132 ,
133 3.4.2.1. Le traitement de première ligne, p.134 ,
135 3.5.1. Les moyens de contrôle de l'éradication, p.136 ,
Gastroentérologie : Rome ressuscitée, Forum Med Suisse, vol.6, pp.1155-1162, 2006. ,
Managing Dyspepsia in a Primary Care Setting, Clinical Medicine & Research, vol.4, issue.4, pp.337-379, 2006. ,
DOI : 10.3121/cmr.4.4.337
Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer., Gut, vol.9, issue.1, pp.75-83, 1968. ,
DOI : 10.1136/gut.9.1.75
Natural history of dyspepsia, Gut, vol.50, issue.Supplement 4, pp.2-9, 2002. ,
DOI : 10.1136/gut.50.suppl_4.iv2
Prevalence of symptoms of dyspepsia in the community., BMJ, vol.298, issue.6665, pp.30-32, 1989. ,
DOI : 10.1136/bmj.298.6665.30
Dyspepsia in England and Scotland., Dyspepsia in England and Scotland, pp.401-406, 1990. ,
DOI : 10.1136/gut.31.4.401
Dyspepsia and dyspepsia subgroups: A population-based study, Gastroenterology, vol.102, issue.4, pp.1259-68, 1992. ,
DOI : 10.1016/0016-5085(92)90764-P
Dyspepsia in consulters and non-consulters, European Journal of Gastroenterology & Hepatology, vol.6, issue.10, 1994. ,
DOI : 10.1097/00042737-199410000-00014
Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time, Gastroenterology, vol.109, issue.3, pp.671-80, 1995. ,
DOI : 10.1016/0016-5085(95)90373-9
Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population, Gut, vol.42, issue.5, pp.690-695, 1998. ,
DOI : 10.1136/gut.42.5.690
The health economic impact of upper gastrointestinal symptoms in the general population : results from the Domestic/International Gastroenterology Surveillance Study (DIGEST), Scan J Gastroenterol, vol.231, issue.34, pp.38-47, 1999. ,
Epidemiologie des troubles intestinaux fonctionnels dans une population saine, Gastroenterol Clin Biol, vol.10, issue.1, pp.7-12, 1986. ,
Diagnostic en médecine générale de l'infection à Helicobacter pylori par le test respiratoire à l'urée 13 C : enquête auprès des praticiens Lorrains, Thèse : Med : UHP Nancy, 200311145. ,
Peptic Ulcer, Non-Ulcer Dyspepsia and Irritable Bowel Syndrome in the Netherlands and Japan, Scandinavian Journal of Gastroenterology, vol.92, issue.sup200, pp.33-41, 1993. ,
DOI : 10.1007/BF01395503
The prevalence and clinical course of functional dyspepsia, Alimentary Pharmacology and Therapeutics, vol.43, issue.6, pp.643-654, 2004. ,
DOI : 10.1046/j.1365-2036.2003.01575.x
Comment explorer et traiter un malade dyspeptique ?, Gastroent??rologie Clinique et Biologique, vol.29, issue.8-9, pp.818-845, 2005. ,
DOI : 10.1016/S0399-8320(05)86353-5
Dyspepsia in the community : a follow-up study, Br J Clin Pract, vol.26, issue.2, pp.95-102, 1992. ,
Onset and Disappearance of Gastrointestinal Symptoms and Functional Gastrointestinal Disorders, American Journal of Epidemiology, vol.136, issue.2, pp.165-77, 1992. ,
DOI : 10.1093/oxfordjournals.aje.a116483
Epidemiology of Upper Dyspepsia in a Random Population: Prevalence, Incidence, Natural History, and Risk Factors, Scandinavian Journal of Gastroenterology, vol.23, issue.1, pp.2-6, 1994. ,
DOI : 10.3109/00365528809093875
Dyspepsia in general practice in Denmark. A 1-year analysis of consulters in general practice, Scand J Prim Health Care, vol.16, issue.4, pp.216-237, 1998. ,
American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia, Gastroenterology, vol.129, issue.5, pp.1756-80, 2005. ,
DOI : 10.1053/j.gastro.2005.09.020
Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community., Gut, vol.35, issue.5, pp.619-643, 1994. ,
DOI : 10.1136/gut.35.5.619
Comparison of coffee intake and coffee-induced symptoms in patients with duodenal ulcer, nonulcer dyspepsia, and normal controls, Am J Gastroenterol, vol.85, issue.10, pp.1339-1381, 1990. ,
Environmental factors and chronic unexplained dyspepsia, Digestive Diseases and Sciences, vol.25, issue.Suppl, pp.641-649, 1988. ,
DOI : 10.1002/cpt1979254481
The Epidemiology of Functional Gastrointestinal Disorders, The European Journal of Surgery, vol.164, issue.0, pp.60-66, 1998. ,
DOI : 10.1080/11024159850191265
One-year prognosis of primary care dyspepsia: predictive value of symptom pattern, Helicobacter pylori and GP management, European Journal of Gastroenterology & Hepatology, vol.14, issue.1, pp.55-60, 2002. ,
DOI : 10.1097/00042737-200201000-00010
Fluctuation in dyspepsia subgroups over time. A three-year follow-up of patients consulting general practice for dyspepsia, Digestive and Liver Disease, vol.34, issue.5, pp.332-340, 2002. ,
DOI : 10.1016/S1590-8658(02)80126-8
Impact of functional dyspepsia on quality of life, Digestive Diseases and Sciences, vol.28, issue.suppl 195, pp.584-593, 1995. ,
DOI : 10.7326/0003-4819-116-2-129
L'infection par Helicobacter pylori doit-elle être prise en compte chez un malade souffrant de dyspepsie?, Gastroenterol Clin Biol, vol.27, issue.3, pp.432-441, 2003. ,
Clinical and economic consequences of dyspepsia in the community, Gut, vol.50, issue.Supplement 4, pp.10-12, 2002. ,
DOI : 10.1136/gut.50.suppl_4.iv10
The Cost of Gastro-Oesophageal Reflux Disease, Dyspepsia and Peptic Ulcer Disease in Sweden, PharmacoEconomics, vol.35, issue.Suppl.11, pp.347-55, 2002. ,
DOI : 10.1080/003655200750023886
Clinical and economic consequences of dyspepsia in the community, Gut, vol.50, issue.Supplement 4, pp.10-12, 2002. ,
DOI : 10.1136/gut.50.suppl_4.iv10
Reducing community dyspepsia drug costs: a controlled trial, Gut, vol.49, issue.4, pp.495-501, 2001. ,
DOI : 10.1136/gut.49.4.495
Helicobacter pylori test and treat strategy for young dyspeptic patients: new data, Gut, vol.50, issue.Supplement 4, pp.47-50, 2002. ,
DOI : 10.1136/gut.50.suppl_4.iv47
A prospective study of dyspepsia in primary care, Digestive Diseases and Sciences, vol.47, issue.4, pp.797-803, 2002. ,
DOI : 10.1023/A:1014748202229
Prevalence of dyspepsia: the epidemiology of overlapping symptoms., Postgraduate Medical Journal, vol.70, issue.821, pp.154-61, 1994. ,
DOI : 10.1136/pgmj.70.821.154
Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy, Gastroenterology, vol.105, issue.5, pp.1378-86, 1993. ,
DOI : 10.1016/0016-5085(93)90142-Y
Functional gastroduodenal disorders, Gut, vol.45, issue.Supplement 2, pp.37-42, 1999. ,
DOI : 10.1136/gut.45.2008.ii37
Predicting Endoscopic Diagnosis in the Dyspeptic Patient: The Value of Predictive Score Models, Scandinavian Journal of Gastroenterology, vol.110, issue.2 ,
DOI : 10.1053/gast.1996.v110.agast960302
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study, Alimentary Pharmacology and Therapeutics, vol.122, issue.2, pp.1481-91, 2003. ,
DOI : 10.1053/gast.2002.33427
Dyspepsia management in the millennium: The death of test and treat?, Gastroenterology, vol.122, issue.5, pp.1521-1526, 2002. ,
DOI : 10.1053/gast.2002.33370
Role of endoscopy and biopsy in the work up of dyspepsia, Gut, vol.50, issue.Supplement 4, pp.13-16, 2002. ,
DOI : 10.1136/gut.50.suppl_4.iv13
Hépato-gastro-entérologie, 2003. ,
Pathophysiology of functional dyspepsia, Gut, vol.51, issue.Supplement 1, pp.63-69, 2002. ,
DOI : 10.1136/gut.51.suppl_1.i63
Risk indicators of organic diseases in uninvestigated dyspepsia, European Journal of Gastroenterology & Hepatology, vol.11, issue.10, pp.1129-1163, 1999. ,
DOI : 10.1097/00042737-199910000-00009
Predominant symptoms identify different subgroups in functional dyspepsia, The American Journal of Gastroenterology, vol.316, issue.182, pp.2080-2085, 1999. ,
DOI : 10.1016/0016-5085(94)90086-8
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia, The American Journal of Gastroenterology, vol.35, issue.4, pp.783-791, 2003. ,
DOI : 10.1136/gut.47.1.11
Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?, The American Journal of Gastroenterology, vol.39, issue.3, pp.1422-1430, 2001. ,
DOI : 10.1023/A:1018834025351
Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia, Gastroenterology, vol.121, issue.3, pp.526-561, 2001. ,
DOI : 10.1053/gast.2001.27180
Impaired drinking capacity in patients with functional dyspepsia: Relationship with proximal stomach function, Gastroenterology, vol.121, issue.5, pp.1054-63, 2001. ,
DOI : 10.1053/gast.2001.28656
Basic and clinical aspects of visceral hyperalgesia, Gastroenterology, vol.107, issue.1, pp.271-93, 1994. ,
DOI : 10.1016/0016-5085(94)90086-8
Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia, Gastroenterology, vol.101, issue.1, pp.3-6, 1991. ,
DOI : 10.1016/0016-5085(91)90453-R
Prise en charge diagnostique et th??rapeutique de l'infection ?? Helicobacter pylori, EMC - Gastro-ent??rologie, vol.3, issue.2, pp.21-31, 2008. ,
DOI : 10.1016/S1155-1968(08)40076-7
Helicobacter pylori, Gastroent??rologie Clinique et Biologique, vol.31, issue.12, pp.1110-1117, 2007. ,
DOI : 10.1016/S0399-8320(07)78346-X
Epidemiology of Helicobacter pylori Infection, Helicobacter, vol.39, issue.s1, pp.1-5, 2006. ,
DOI : 10.1080/00365520510015917
Symptom Patterns and Pathophysiological Mechanisms in Dyspeptic Patients with and Without Helicobacter pylori, Digestive Diseases and Sciences, vol.48, issue.12, pp.2229-2265, 2003. ,
DOI : 10.1023/B:DDAS.0000007856.71462.6c
Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia?, Gut, vol.37, issue.1, pp.47-51, 1995. ,
DOI : 10.1136/gut.37.1.47
Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function, Gut, vol.44, issue.1, pp.55-64, 1999. ,
DOI : 10.1136/gut.44.1.55
Medically Unexplained Physical Symptoms, Anxiety, and Depression, Psychosomatic Medicine, vol.65, issue.4, pp.528-561, 2003. ,
DOI : 10.1097/01.PSY.0000075977.90337.E7
Psychosocial Correlates of Symptoms in Functional Dyspepsia, Clinical Gastroenterology and Hepatology, vol.3, issue.6, pp.521-529, 2005. ,
DOI : 10.1016/S1542-3565(05)00245-4
Gastrointestinal tract symptoms and self-reported abuse: A population-based study, Gastroenterology, vol.107, issue.4, pp.1040-1049, 1994. ,
DOI : 10.1016/0016-5085(94)90228-3
Discriminant analysis of factors distinguishing patients with functional dyspepsia from patients with duodenal ulcer, Digestive Diseases and Sciences, vol.314, issue.suppl 128, pp.1105-1116, 1995. ,
DOI : 10.1016/S0016-5085(88)80006-4
Does psychological distress modulate functional gastrointestinal symptoms and health care seeking? A prospective, community cohort study, The American Journal of Gastroenterology, vol.83, issue.4, pp.789-97, 2003. ,
DOI : 10.1016/0022-3956(86)90005-1
Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice?, European Journal of Gastroenterology & Hepatology, vol.11, issue.8, pp.881-887, 1999. ,
DOI : 10.1097/00042737-199908000-00012
A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia, Gastroenterology, vol.119, issue.3, pp.661-669, 2000. ,
DOI : 10.1053/gast.2000.16493
Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia, Gastroenterology, vol.124, issue.4, pp.903-913, 2003. ,
DOI : 10.1053/gast.2003.50155
Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia, Alimentary Pharmacology and Therapeutics, vol.41, issue.6, pp.841-851, 2003. ,
DOI : 10.1007/s001270050026
Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome, Gastroenterology, vol.99, issue.2, pp.327-360, 1990. ,
DOI : 10.1016/0016-5085(90)91012-U
Comment faire passer les nouvelles connaissances dans la pratique? (Editorial) Hépato-gastro, 2004. ,
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, Gut, vol.56, issue.6, pp.772-781, 2007. ,
DOI : 10.1136/gut.2006.101634
American College of Gastroenterology Guideline on the Management of Helicobacter pylori Infection, The American Journal of Gastroenterology, vol.11, issue.2, pp.1808-1833, 2007. ,
DOI : 10.1111/j.1523-5378.2006.00436.x
Recommandations d'éradication de Helicobacter pylori en, Hépato-gastro, vol.15, issue.5, pp.363-70, 2008. ,
Helicobacter pylori, Gastroent??rologie Clinique et Biologique, vol.31, issue.12, pp.189-91, 2007. ,
DOI : 10.1016/S0399-8320(07)78346-X
Current Guidelines for Dyspepsia Management, Digestive Diseases, vol.128, issue.3, pp.225-255, 2008. ,
DOI : 10.1155/2005/674607
???Test and treat??? strategy for management of uninvestigated dyspepsia: A meta-analysis, Gastroenterology, vol.120, issue.5, p.89, 2001. ,
DOI : 10.1016/S0016-5085(08)80439-8
Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment---Helicobacter pylori positive (CADET-Hp) randomised controlled trial, BMJ, vol.324, issue.7344, pp.1012-1019, 2002. ,
DOI : 10.1136/bmj.324.7344.1012
A Randomized Controlled Trial of Test-and-Treat Strategy for Helicobacter pylori, Archives of Internal Medicine, vol.163, issue.10, pp.1165-71, 2003. ,
DOI : 10.1001/archinte.163.10.1165
Empirical prescribing for dyspepsia, European Journal of Gastroenterology & Hepatology, vol.15, issue.7, p.1118, 2003. ,
DOI : 10.1097/00042737-200307000-00022
A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic, Gut, vol.45, issue.2, pp.186-90, 1999. ,
DOI : 10.1136/gut.45.2.186
Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting, Family Practice, vol.21, issue.3, pp.238-281, 2004. ,
DOI : 10.1093/fampra/cmh304
Approach to Treatment of Dyspepsia in Primary Care, Archives of Internal Medicine, vol.163, issue.13, pp.1606-1618, 2003. ,
DOI : 10.1001/archinte.163.13.1606
Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial, The Lancet, vol.356, issue.9228, pp.455-60, 2000. ,
DOI : 10.1016/S0140-6736(00)02553-8
Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia, BMJ, vol.324, issue.7344, pp.999-1006, 2002. ,
DOI : 10.1136/bmj.324.7344.999
A trial of a test-and-treat strategy for Helicobacter pylori positive dyspeptic patients in general practice, Int J Clin Pract, vol.53, issue.6, pp.413-419, 1999. ,
Initial Management strategies for dyspepsia, Cochrane Database Syst Rev, issue.2, p.1961, 2003. ,
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia, European Journal of Gastroenterology & Hepatology, vol.8, issue.3, pp.72-83, 1996. ,
DOI : 10.1097/00042737-199603000-00021
Alternative Management Strategies for Patients with Suspected Peptic Ulcer Disease, Annals of Internal Medicine, vol.123, issue.4, pp.260-268, 1995. ,
DOI : 10.7326/0003-4819-123-4-199508150-00003
Management Strategies for Helicobacter pylori-Seropositive Patients with Dyspepsia: Clinical and Economic Consequences, Annals of Internal Medicine, vol.126, issue.4, pp.280-91, 1997. ,
DOI : 10.7326/0003-4819-126-4-199702150-00004
Dyspepsia management in primary care: A decision analysis of competing strategies, Gastroenterology, vol.122, issue.5, pp.1270-85, 2002. ,
DOI : 10.1053/gast.2002.33019
Helicobacter pylori test-and-treat intervention compared to usual care in primary care patients with suspected peptic ulcer disease in the United States, The American Journal of Gastroenterology, vol.120, issue.12, pp.3007-3021, 2002. ,
DOI : 10.1136/bmj.321.7262.659
Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects, Am J Gastroenterol, vol.91, issue.9, pp.1773-1780, 1996. ,
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia, Gut, vol.53, issue.5, pp.666-72, 2004. ,
DOI : 10.1136/gut.2003.021857
Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study, Gut, vol.49, issue.1, pp.29-34, 2001. ,
DOI : 10.1136/gut.49.1.29
Current guidelines fail young patients with oesophagogastric cancer, Gut, vol.51, issue.2, pp.296-97, 2002. ,
DOI : 10.1136/gut.51.2.296-a
Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia, Gut, vol.41, issue.4, pp.513-520, 1997. ,
DOI : 10.1136/gut.41.4.513
Peptic ulcer disease today, Nature Clinical Practice Gastroenterology & Hepatology, vol.128, issue.Suppl 1, 2006. ,
DOI : 10.1053/j.gastro.2005.01.009
Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary, BMJ, vol.322, issue.7291, pp.898-901, 2001. ,
DOI : 10.1136/bmj.322.7291.898
Age threshold for endoscopy and risk of missing upper gastrointestinal malignancy - data from the Scottish audit of gastric and oesophageal cancer, Alimentary Pharmacology and Therapeutics, vol.36, issue.2, pp.229-262, 2006. ,
DOI : 10.1016/S0140-6736(88)90879-3
Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia, Gut, vol.46, issue.1, pp.93-100, 2000. ,
DOI : 10.1136/gut.46.1.93
Upper GI malignancy, uncomplicated dyspepsia, and the age threshold for early endoscopy, The American Journal of Gastroenterology, vol.114, issue.182, pp.600-603, 2002. ,
DOI : 10.1016/S0002-9270(98)00655-8
Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients less than 55?, Gut, vol.94, issue.1, pp.75-84, 1999. ,
Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care, The Lancet, vol.356, issue.9246, pp.1965-1974, 2000. ,
DOI : 10.1016/S0140-6736(00)03308-0
Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasm, Scand J Gastroenterol, vol.38, issue.1, pp.109-122, 2003. ,
Yield of endoscopy in dyspepsia and concurrent treatment with proton pump inhibitors: The blind leading the blind?, Gastrointestinal Endoscopy, vol.58, issue.1, pp.89-92, 2003. ,
DOI : 10.1067/mge.2003.302
The Loiano-Monghidoro population-based study of Helicobacter pylori infection: prevalence by 13C-urea breath test and associated factors, Alimentary Pharmacology and Therapeutics, vol.103, issue.7, pp.1001-1008, 2001. ,
DOI : 10.1016/0016-5085(92)90004-I
Helicobacter pylori infection and dyspepsia, Scand J Gastroenterol, vol.215, pp.38-47, 1996. ,
Avantages et inconvéniants des différentes méthodes diagnostiques de l'infection à H. pylori, Gastroenterol Clin Biol, vol.27, pp.380-90, 2003. ,
Infection among Adults in the United States, The Journal of Infectious Diseases, vol.181, issue.4, pp.1359-63, 2000. ,
DOI : 10.1086/315384
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists, Gastroenterology, vol.102, issue.1, pp.41-47, 1992. ,
DOI : 10.1016/0016-5085(92)91782-Y
Incidence of digestive tract cancers by region, Gastroenterol Clin Biol, vol.23, issue.10, pp.1040-1047, 1999. ,
Gastric Cancer and Helicobacter pylori : a combined analysis of 12 case control cohort studies nested within prospective cohorts, Gut, vol.49, pp.347-53, 2001. ,
What happens to patients following open access gastroscopy? An outcome study from general practice ,
Does endoscopy have a positive impact on quality of life in dyspepsia?, Gastrointestinal Endoscopy, vol.47, issue.6, pp.449-54, 1998. ,
DOI : 10.1016/S0016-5107(98)70243-3
Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia, Alimentary Pharmacology and Therapeutics, vol.159, issue.2, pp.835-875, 2003. ,
DOI : 10.1001/archinte.156.8.873
The effectiveness of endoscopy in the management of dyspepsia, European Journal of Gastroenterology & Hepatology, vol.11, issue.5, pp.335-381, 1999. ,
DOI : 10.1097/00042737-199905000-00023
Evaluation de la prise en charge initiale de la dyspepsie de l'adulte en médecine générale en France, Thèse : Med : Paris 5 Necker, 200105089. ,
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial, Gut, vol.55, issue.4, pp.457-62, 2006. ,
DOI : 10.1136/gut.2005.078626
Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection - a critical review, Alimentary Pharmacology and Therapeutics, vol.15, issue.3, pp.1001-1018, 2004. ,
DOI : 10.1111/j.1083-4389.2004.00191.x
Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments, The American Journal of Gastroenterology, vol.97, issue.11, pp.2756-62, 2002. ,
DOI : 10.1111/j.1572-0241.2002.07065.x
Diagnosis of Helicobacter pylori Infection, Helicobacter, vol.11, issue.s1, pp.6-13, 2006. ,
DOI : 10.1128/JCM.43.6.2598-2601.2005
Long-term follow-up of 13C-urea breath test results after Helicobacter pylori eradication: frequency and significance of borderline delta13CO2 values, Alimentary Pharmacology and Therapeutics, vol.95, issue.3, pp.275-80, 2006. ,
DOI : 10.1111/j.1083-4389.2004.00191.x
The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients., Gut, vol.40, issue.3, pp.302-308, 1997. ,
DOI : 10.1136/gut.40.3.302
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C Urea Breath Tests and Stool Test for Helicobacter Pylori Infection, The American Journal of Gastroenterology, vol.93, issue.1, pp.823-832, 2004. ,
DOI : 10.1016/S0002-9270(98)00293-7
Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors, The American Journal of Gastroenterology, vol.84, issue.5, pp.1005-1014, 2003. ,
DOI : 10.1046/j.1365-2036.2002.01192.x
Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections, World Journal of Gastroenterology, vol.8, issue.4, pp.703-709, 2002. ,
DOI : 10.1093/jac/47.4.459
Selection of lower cut-off point of 13C-urea breath test is helpful to monitor Helicobacter pylori eradication after proton pump inhibitor-based triple therapy, Digestive Diseases and Sciences, vol.45, issue.7, pp.1330-1336, 2000. ,
DOI : 10.1023/A:1005599818959
Accurate Diagnosis of Helicobacter pylori, Gastroenterology Clinics of North America, vol.29, issue.4, pp.853-62, 2000. ,
DOI : 10.1016/S0889-8553(05)70152-7
rapid blood tests in a multi-ethnic Asian population, World Journal of Gastroenterology, vol.11, issue.42, pp.6681-6684, 2005. ,
DOI : 10.1046/j.1365-2036.2002.01169.x
The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis, Gastroenterology, vol.127, issue.5, pp.1329-1366, 2004. ,
DOI : 10.1053/j.gastro.2004.08.026
Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients, Gut, vol.51, issue.4, pp.502-508, 2002. ,
DOI : 10.1136/gut.51.4.502
Lansoprazole in the treatment of functional dyspepsia: Two Double-Blind, Randomized, Placebo-Controlled trials, The American Journal of Medicine, vol.116, issue.11, pp.740-748, 2004. ,
DOI : 10.1016/j.amjmed.2004.01.008
Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies), Alimentary Pharmacology and Therapeutics, vol.10, issue.11, pp.1055-65, 1998. ,
DOI : 10.1097/00042737-199802000-00004
The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies, Gut, vol.50, issue.Supplement 4, pp.36-41, 2002. ,
DOI : 10.1136/gut.50.suppl_4.iv36
Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status, Gut, vol.47, issue.4, pp.473-80, 2000. ,
DOI : 10.1136/gut.47.4.473
Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome, Alimentary Pharmacology and Therapeutics, vol.3, issue.133, pp.981-989, 2004. ,
DOI : 10.1016/S0344-0338(78)80028-4
Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy, Gut, vol.46, issue.4, pp.464-471, 2000. ,
DOI : 10.1136/gut.46.4.464
Therapeutic Options in Nonulcer Dyspepsia, Journal of Clinical Gastroenterology, vol.32, issue.4, pp.286-93, 2001. ,
DOI : 10.1097/00004836-200104000-00004
Traitement d???une dyspepsie, Gastroent??rologie Clinique et Biologique, vol.30, issue.3, pp.408-422, 2006. ,
DOI : 10.1016/S0399-8320(06)73195-5
Psychological interventions for non-ulcer dyspepsia, Cochrane Database Syst Rev, issue.2, p.2301, 2004. ,
Helicobacter pylori and reflux disease, Alimentary Pharmacology and Therapeutics, vol.19, issue.6, pp.297-305, 2003. ,
DOI : 10.1016/S0016-5085(98)70364-6
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer, Gut, vol.42, issue.5, pp.618-640, 1998. ,
DOI : 10.1136/gut.42.5.618
Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease, The American Journal of Gastroenterology, vol.34, issue.12, pp.3015-3037, 2002. ,
DOI : 10.1097/00004836-199701000-00002
Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated, The American Journal of Gastroenterology, vol.91, issue.8, pp.1834-1874, 1999. ,
DOI : 10.1016/0016-5085(92)91716-H
Gastrites chroniques, EMC - Gastro-ent??rologie, vol.1, issue.1, pp.9-017 ,
DOI : 10.1016/S1155-1968(03)00072-5
Pathogenesis of Helicobacter pylori Infection, Clinical Microbiology Reviews, vol.19, issue.3, pp.449-90, 2006. ,
DOI : 10.1128/CMR.00054-05
Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis, The Lancet, vol.359, issue.9300, pp.14-22, 2002. ,
DOI : 10.1016/S0140-6736(02)07273-2
Ulc??re duod??nal et infection ?? Helicobacter pylori, Gastroent??rologie Clinique et Biologique, vol.31, issue.12, pp.1119-1139, 2007. ,
DOI : 10.1016/S0399-8320(07)78347-1
Infection and the Development of Gastric Cancer, New England Journal of Medicine, vol.345, issue.11, pp.784-793, 2001. ,
DOI : 10.1056/NEJMoa001999
Is there a link between the variation of gastric cancer mortality and differences in Helicobacter pylori prevalence in different regions of France, Gastroenterol Clin Biol, vol.23, pp.6-7754, 1999. ,
Meta-analysis of the relationship between cagA seropositivity and gastric cancer, Gastroenterology, vol.125, issue.6, pp.1926-1933, 2004. ,
DOI : 10.1053/j.gastro.2003.08.033
Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma, CancerSpectrum Knowledge Environment, vol.94, issue.22, pp.1680-1687, 2002. ,
DOI : 10.1093/jnci/94.22.1680
Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori, Gastroenterology, vol.118, issue.1, pp.22-30, 2000. ,
DOI : 10.1016/S0016-5085(00)70410-0
The Long-term Impact of Helicobacter??pylori Eradication on Gastric Histology: a Systematic Review and Meta-analysis, Helicobacter, vol.11, issue.1, pp.32-40, 2007. ,
DOI : 10.1046/j.1365-2036.2002.01346.x
Dyspepsie non ulcéreuse et Helicobacter pylori : Existe-t-il un profil symptomatique spécifique? Etude prospective chez 258 patients, Thèse : Med : UHP Nancy, 199711070. ,
Questions au Professeur Jean-Charles Delchier, Gastroent??rologie Clinique et Biologique, vol.31, issue.12, pp.1121-1124, 2007. ,
DOI : 10.1016/S0399-8320(07)78348-3
Quand et comment contrôler l'éradication de Helicobacter pylori après un traitement de première ligne?, Gastroenterol Clin Biol, vol.27, issue.3, pp.473-480, 2003. ,
Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial, The Lancet, vol.355, issue.9216, pp.1665-1674, 2000. ,
DOI : 10.1016/S0140-6736(00)02236-4
in Patients with Nonulcer Dyspepsia, New England Journal of Medicine, vol.341, issue.15, pp.1106-1117, 1999. ,
DOI : 10.1056/NEJM199910073411502
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial, Gut, vol.53, issue.1, pp.12-20, 2004. ,
DOI : 10.1136/gut.53.1.12
Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies, The American Journal of Gastroenterology, vol.35, issue.12, pp.2992-2999, 2002. ,
DOI : 10.1067/mge.2002.122617
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease, Gastroenterology, vol.121, issue.5, pp.1120-1126, 2001. ,
DOI : 10.1053/gast.2001.29332
Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia, Alimentary Pharmacology and Therapeutics, vol.32, issue.1, pp.55-63, 2006. ,
DOI : 10.1111/j.1572-0241.2003.08724.x
The effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis, Alimentary Pharmacology and Therapeutics, vol.16, issue.1, pp.733-777, 2004. ,
DOI : 10.1046/j.1365-2036.2002.01169.x
Symptom Response and Healing of Erosive Esophagitis with Proton-Pump Inhibitors in Patients with Helicobacter pylori Infection, The American Journal of Gastroenterology, vol.115, issue.1, pp.1437-1478, 2004. ,
DOI : 10.1111/j.1572-0241.2001.05263.x
Treatment of gastro-oesophageal reflux disease with rabeprazole in primary and secondary care: does Helicobacter pylori infection affect proton pump inhibitor effectiveness?, Alimentary Pharmacology and Therapeutics, vol.98, issue.4, pp.451-459, 2004. ,
DOI : 10.1016/S1590-8658(01)80100-6
There is no difference in the disease severity of gastro-oesophageal reflux disease between patients infected and not infected with Helicobacter pylori, Alimentary Pharmacology and Therapeutics, vol.45, issue.1, pp.761-769, 2004. ,
DOI : 10.1007/BF00191963
A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer, Alimentary Pharmacology and Therapeutics, vol.15, issue.12, pp.1949-58, 2001. ,
DOI : 10.1053/gast.1997.v113.pm9322501
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence A 10 years' endoscopical survey, World Journal of Gastroenterology, vol.12, issue.15, pp.122398-2401, 2006. ,
DOI : 10.1023/A:1012731614075
Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up, The Lancet, vol.343, issue.8892, pp.258-60, 1994. ,
DOI : 10.1016/S0140-6736(94)91111-8
Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis, The American Journal of Gastroenterology, vol.312, issue.2, pp.1833-55, 2004. ,
DOI : 10.1136/bmj.312.7027.349
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use, New England Journal of Medicine, vol.346, issue.26, pp.2033-2041, 2002. ,
DOI : 10.1056/NEJMoa012877
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial, The Lancet, vol.359, issue.9300, pp.9-13, 2002. ,
DOI : 10.1016/S0140-6736(02)07272-0
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs, European Journal of Gastroenterology & Hepatology, vol.10, issue.11, pp.1016-1037, 1998. ,
DOI : 10.1097/00042737-199811000-00018
Infection Who Are Taking Low-Dose Aspirin or Naproxen, New England Journal of Medicine, vol.344, issue.13, pp.967-73, 2001. ,
DOI : 10.1056/NEJM200103293441304
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users - a randomized trial, Alimentary Pharmacology and Therapeutics, vol.91, issue.8, pp.829-865, 2003. ,
DOI : 10.1136/gut.51.3.336
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage, Alimentary Pharmacology and Therapeutics, vol.15, issue.12, pp.1939-1986, 2001. ,
DOI : 10.1111/j.1572-0241.1998.00684.x
Maintenance Treatment Is Not Necessary After Helicobacter pylori Eradication and Healing of Bleeding Peptic Ulcer, Archives of Internal Medicine, vol.163, issue.17, pp.2020-2024, 2003. ,
DOI : 10.1001/archinte.163.17.2020
Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer, Alimentary Pharmacology and Therapeutics, vol.12, issue.3, pp.617-646, 2004. ,
DOI : 10.1111/j.1572-0241.2002.05904.x
Helicobacter pylori Eradication for the Prevention of Gastric Cancer, Helicobacter, vol.128, issue.s1, pp.52-59, 2006. ,
DOI : 10.1136/gut.53.1.12
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication, Gut, vol.53, issue.9, pp.1244-1253, 2004. ,
DOI : 10.1136/gut.2003.034629
Helicobacter pylori Eradication and Gastric Preneoplastic Conditions: A Randomized, Double-Blind, Placebo-Controlled Trial, Cancer Epidemiology Biomarkers & Prevention, vol.13, issue.1, pp.4-10, 2004. ,
DOI : 10.1158/1055-9965.EPI-03-0124
Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori Therapy, Journal of the National Cancer Institute, vol.92, issue.23, pp.1881-1889, 2000. ,
DOI : 10.1093/jnci/92.23.1881
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China, JAMA, vol.291, issue.2, pp.187-94, 2004. ,
DOI : 10.1001/jama.291.2.187
Long term follow up of patients treated for Helicobacter pylori infection, Gut, vol.54, issue.11, pp.1536-1576, 2005. ,
DOI : 10.1136/gut.2005.072009
The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease, The American Journal of Gastroenterology, vol.125, issue.5, pp.1037-1079, 2005. ,
DOI : 10.1007/s10120-003-0265-0
Long-term clinical outcome ofHelicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment, Cancer, vol.60, issue.3, pp.532-572, 2005. ,
DOI : 10.3109/10428199909093738
Synchronous Adenocarcinoma and Mucosa-associated Lymphoid Tissue (MALT) Lymphoma in a Single Stomach, Japanese Journal of Clinical Oncology, vol.35, issue.10, pp.591-595, 2005. ,
DOI : 10.1016/S0140-6736(94)91254-8
eradication and beyond, Expert Review of Anticancer Therapy, vol.100, issue.3, pp.361-71, 2006. ,
DOI : 10.1200/JCO.2005.05.660
Long-Term Results of Anti???
Helicobacter pylori
Therapy in Early-Stage Gastric High-Grade Transformed MALT Lymphoma, JNCI: Journal of the National Cancer Institute, vol.97, issue.18, pp.1345-53, 2005. ,
DOI : 10.1200/JCO.2004.10.087
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12??months' follow up, BMJ, vol.318, issue.7187, pp.833-840, 1999. ,
DOI : 10.1136/bmj.318.7187.833
Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms?, Gut, vol.50, issue.Supplement 4, pp.26-30, 2002. ,
DOI : 10.1136/gut.50.suppl_4.iv26
Infection in Patients with Nonulcer Dyspepsia, New England Journal of Medicine, vol.339, issue.26, pp.1869-74, 1998. ,
DOI : 10.1056/NEJM199812243392601
in Patients with Nonulcer Dyspepsia, Annals of Internal Medicine, vol.134, issue.5, pp.361-370, 2001. ,
DOI : 10.7326/0003-4819-134-5-200103060-00008
Eradication of Helicobacter pylori for non-ulcer dyspepsia, Cochrane Database Syst Rev, issue.2, p.2096, 2000. ,
Helicobacter pylori eradication in long-term proton pump inhibitor users is highly cost-effective : economic analysis of the HELPUP trial, Aliment Pharmacol Ther, vol.28, pp.11-121297, 2008. ,
Does Helicobacter pylori Eradication Affect Symptoms in Nonulcer Dyspepsia: A 5-Year Follow-Up Study, Helicobacter, vol.11, issue.318, pp.317-338, 2002. ,
DOI : 10.1097/00042737-199906001-00006
Prise en charge thérapeutique de l'éradication de Helicobacter pylori chez l'adulte et chez l'enfant, 2005. ,
High eradication rates of Helicobacter pylori with a new sequential treatment, Alimentary Pharmacology and Therapeutics, vol.34, issue.5, pp.719-745, 2003. ,
DOI : 10.1046/j.1365-2036.2000.00719.x
Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication, Alimentary Pharmacology and Therapeutics, vol.11, issue.6, pp.647-54, 2003. ,
DOI : 10.1046/j.1365-2036.2002.01270.x
Procédures d'éradication et de contrôle d'éradication. Une étude prospective comparative entre 2 centres de gastro-entérologie en Lorraine, Thèse : Med : UHP NANCY, 2010. ,
Quel traitement peut-on proposer après un échec d'éradication de Helicobacter pylori?, Gastroenterol Clin Biol, vol.27, issue.3, pp.478-83, 2003. ,
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies, Alimentary Pharmacology and Therapeutics, vol.86, issue.8, pp.791-798, 2003. ,
DOI : 10.1080/003655201300191941
H pylori antibiotic resistance: prevalence, importance, and advances in testing, Gut, vol.53, issue.9, pp.1374-84, 2004. ,
DOI : 10.1136/gut.2003.022111
Review article: the treatment of refractory Helicobacter pylori infection, Alimentary Pharmacology and Therapeutics, vol.45, issue.345, pp.1333-1376, 2003. ,
DOI : 10.1128/JCM.41.1.397-402.2003
Infections, Annals of Internal Medicine, vol.139, issue.6, pp.463-70, 2003. ,
DOI : 10.7326/0003-4819-139-6-200309160-00008
Impact of Clarithromycin Resistance on Eradication of Helicobacter pylori in Infected Adults, Antimicrobial Agents and Chemotherapy, vol.49, issue.4, pp.1600-1603, 2005. ,
DOI : 10.1128/AAC.49.4.1600-1603.2005
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure, Alimentary Pharmacology and Therapeutics, vol.83, issue.2, pp.35-44, 2006. ,
DOI : 10.1111/j.1365-2036.2005.02622.x
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin, Alimentary Pharmacology and Therapeutics, vol.50, issue.2, pp.395-403, 2006. ,
DOI : 10.1067/mcp.2001.113959
13-10 comparaison du traitement en cas de persistance des symptômes malgré une éradication efficace, tableau 3.4.13-9 comparaison du traitement en, p.95 ,
72 figure 3.4.2-3 ensemble des résultats attendus à la gastroscopie en fonction de tous les médecins répondeurs, figure 3.4.2-2 autres résultats attendus, p.74 ,